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Abstract
Tumors of the mammary glands are the most common neoplasms in dogs in our country; however, there are few 
Brazilian reports dedicated to clinicopathological and survival studies about this disease. This report aims the clinical 
and pathological study of canine mammary tumors in the Santos Metropolitan Region, an area in Sao Paulo state with 
an estimated canine population of 120,000 animals. Data of 14,298 dogs were collected retrospectively from the medical 
records of the Veterinary Medical Teaching Hospital of the Metropolitan University of Santos – São Paulo – Brazil. 
During the study period, from records of 317 females with histopathological diagnosis of neoplasia, 170 were mammary 
epithelial lesions distributed in 13 benign tumors, 152 malignant (89.4% of diagnosis) and 5 non-neoplasic epithelial 
lesions (ductal hyperplasia). The highest prevalent malignant tumor was tubular carcinoma (38.2% of diagnosis) and 
Grade I tumors, corresponding to 73.0% of all diagnosis. The results have shown clinical staging of canine mammary 
neoplasms as an important prognostic survival factor and, in a multivariate analysis, tumor diameter, tumor grade, 
adjuvant chemotherapy and recurrence as covariates with predictive value for survival. Moreover, the high prevalence 
of tubular carcinoma qualifies the canine population of Santos as a promising model for the translational study of this 
disease.
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Resumo
Os tumores das glândulas mamárias são as neoplasias mais comuns em cadelas em nosso país; no entanto, são poucos 
os trabalhos brasileiros dedicados ao estudo clinicopatológico e de sobrevida nesta doença. O presente trabalho teve por 
objetivo o estudo clínico e patológico dos tumores mamários caninos na Região Metropolitana de Santos, uma área no 
estado de São Paulo com uma população canina estimada em 120 mil animais. Dados de 14.298 cães foram coletados 
retrospectivamente dos prontuários médicos do Hospital Veterinário da Universidade Metropolitana de Santos – São 
Paulo – Brasil. Durante o período do estudo, foram atendidas 317 fêmeas com diagnóstico histopatológico de neopla-
sia, dos quais, 170 se referiam a lesões mamárias epiteliais distribuídas em 13 tumores benignos, 152 malignos (89,4% 
dos diagnósticos) e 5 lesões epiteliais não-neoplásicas (hiperplasia ductal). O tumor mais frequente foi o carcinoma 
tubular (38,2% dos tumores malignos) e tumores de grau I, respondendo por 73,0% do total diagnosticado. Estudos de 
sobrevida apontaram para o estadiamento clínico das neoplasias mamárias caninas como importante fator prognóstico, 
e na análise multivariada, diâmetro do tumor, grau histológico, quimioterapia adjuvante e recorrência apresentaram-se 
como covariáveis com valor preditivo de sobrevida. Levando-se em conta a elevada prevalência de carcinoma tubular 
simples na população canina de Santos, pode-se considerá-la como promissor modelo translacional para o estudo da 
doença.
Palavras-chave: Estadiamento. Quimioterapia. Recidiva. Sobrevida. Diâmetro tumoral. 
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Introduction
Cancer is a leading cause of death in both humans 
and canines and their predictable behavior of 
malignancy and metastatic pattern qualify the 
naturally occurring cancer in dogs as a model for 
the study of breast cancer in humans, not possible 
with other animal model system (PINHO et al., 
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2012; PORRELLO; CARDELLI; SPUGNINI, 2006). 
Dogs are also exposed to the same factors that affect 
tumor initiation and progression in humans, such 
as age, hormones, nutritional factors, reproductive 
status and environmental factors (KHANNA et 
al., 2006; PAOLONI; KHANNA, 2007; UVA et al., 
2009). Additionally, the genetic sequencing of canine 
genome highlighted its close relationship with the 
human genome (DAGLI, 2006; KHANNA et al., 2006; 
UVA et al., 2009), pointing out the involvement of the 
same oncogenes and signaling pathways as in human 
carcinogenesis (PINHO et al., 2012).
In some regions of the world, mammary gland 
tumors are the most common neoplasms in female 
dogs, a disease that represents a highly heterogeneous 
group in terms of morphology and biological behavior 
(GAMA; ALVES; SCHIMITT, 2008; NERURKAR et 
al., 1989). Although the prevalence of these tumors 
is decreasing in regions where preventive sterilization 
is performed, it still remains an important disease 
in veterinary medicine (SLEECKX et al., 2011). In 
developed countries, it is reported that about 50% 
of canine mammary tumors are malignant and the 
recognition of reliable prognostic factors is essential 
to identifying the individual risks of unfavorable 
clinical onset (CASSALI et al., 2011; DAGLI, 
2006; NERURKAR et al., 1989) such as tumor size, 
histological type, histological grading and lymph 
node involvement (DAGLI, 2006; CASSALI et al., 
2011; PÉREZ-ALENZA et al. 2000; YAMAGAMI et 
al., 1996).
The present study aims to assess the clinical and 
pathological behavior of canine mammary tumors 
and survival of female dogs related to this disease, 
in Santos Metropolitan Region, São Paulo State, an 
area with a human population of 1.6 million people 
according to 2010 Census of the Brazilian Institute 
of Geography and Statistics – IBGE (INSTITUTO 
BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA, 
2013) and a canine population estimated in 120,000 
animals.
Material and Methods
Medical records of 14,298 dogs examined at 
the Veterinary Medical Teaching Hospital of the 
Metropolitan University of Santos between 2005 
and 2010 were retrospectively reviewed for clinical 
diagnosis of mammary neoplasm. 
Cases were eligible for inclusion in this study when 
main histological diagnosis of benign mammary 
lesion or mammary carcinoma was confirmed; if 
adequate follow-up information was available and 
the minimum follow-up of 18 months starting 
with mastectomy date was accomplished. Records 
of females with no mammary gland tumors, like 
sarcomas or round cell tumors, were not included.
The clinical information obtained from medical 
records included sex, breed and weight, age at 
diagnosis, reproductive status and age at surgical 
sterilization, number and location of affected glands, 
pulmonary and lymph nodes involvement, laboratorial 
exams (blood count, renal and liver function tests), 
previous treatments, histological classification and 
tumor grade. Information about the survival time was 
performed by telephone contact with animal owners. 
For statistical purposes, the animals were grouped 
into sizes: large/giant: > 25 kg; medium size: > 15 
kg to < 25 kg; small: > 5 kg to < 15 kg and toy < 5 kg.
Clinical stage was assigned according to WHO 
TNM classification (OWEN, 1980). Tumor size was 
identified as the maximum diameter of the largest 
tumor in dogs with more than one tumor, as previous 
proposed (SORENMO et al., 2011). Distant metastasis, 
such as involvement of lungs was investigated by 
three-way thoracic radiography while lymph nodes 
involvement was investigated by cytological and/or 
histological examinations.
The slides of the tumors, previously classified 
according to Misdorp et al. (1999), were reevaluated 
according to the criteria proposed by Cassali et al. 
(2011), whereas histological grading was based on 
the Elston and Ellis method as described (CASSALI 
et al., 2011; GAMA; ALVES; SCHIMITT, 2008; 
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KARAYANNOPOULUS et al., 2005; SLEECKX 
et al., 2011). According to medical records, only 
fragments of the greatest tumor were considered for 
histopathological study, regardless to the number of 
aff ected glands.
Mammary gland tumor was considered cause 
of death only when unequivocal evidence such as 
euthanasia due to the metastatic disease or death by 
mammary gland neoplastic cachexia was reported by 
owners or clinicians.
Th e statistical analysis was performed using 
commercial soft ware (Graphpad Prism® v.5.0 or 
Medcalc® v.12.3.0), considering statistically signifi cant 
P < 0.05. 
Overall survival time was calculated from the date 
of surgical removal of the tumor to the date of death, 
which was considered the endpoint of the study. 
Only animals with malignant mammary disease were 
computed in survival analysis. Kaplan-Meier method 
was used to compute overall survival time while the 
log-rank test was used to identify factors associated 
with survival aft er mastectomy. Deaths unrelated to 
the mammary gland tumors or animals that were lost 
to follow-up were considered censored for statistical 
purposes. Th e Cox proportional hazards model 
was used as univariate and multivariate analysis in 
search of factors potentially associated with survival. 
Variables of biological importance or that were found 
to be signifi cant in univariate analyses were selectively 
included in the forward multivariate model.
Results
Of the 14,298 medical records of this study, there 
were 317 female with diagnosis of neoplastic disease 
including 170 mammary lesions from epithelial and 
myoepithelial origin, corresponding to 53.6% of 
all neoplastic diagnosis in this gender. Among the 
diagnoses of mammary cancer, 7.6% (13/170 females) 
had benign tumors diagnosis while malignant 
tumors accounted for 89.4% (152/170 females). Th e 
highest frequent histological tumor type was tubular 
carcinoma (38.2%) and grade I tumors, accounting 
for 73.0% of total diagnosis, as summarized in table 1.
Survival analysis related to malignant histological 
tumor type did not show any statistical diff erence 
between groups, as demonstrated in fi gure 1. However, 
the survival rate evaluating tumor grade as a predictor 
variable, showed a highly signifi cant statistical 
diff erence between them, as shown in fi gure 2.
Table 1 – Distribution of mammary epithelial lesion by histological type and grade in Santos – Sao Paulo – Brasil – 2014
    Grade
Lesion Type** Frequency I II III
NNEL* Ductal hyperplasia 5 (2.9%)   
 Adenoma 7 (4.1%)   
Benign Complex adenoma 4 (2.4%)   
 Mixed benign tumor 2 (1.2%)   
 Benign subtotal 13 (7.6%)   
 Tubular carcinoma 65 (38.2%) 54 (35.5%) 10 (6.6%) 1 (0.7%)
 Complex carcinoma 46 (27.1%) 35 (23.0%) 11 (7.2%) 
Malignant Mixed carcinoma 16 (9.4%) 15 (9.9%) 1 (0.7%) 
 Solid carcinoma 14 (8.2%)  1 (0.7%) 13 (8.6%)
 Papillary carcinoma 9 (5.3%) 7 (4.6%) 2 (1.3%) 
 Ductal carcinoma in situ 2 (1.2%)   
 Malignant subtotal 152 (89.4%) 111 (73.0%) 25 (16.4%) 14 (9.2%)
 Total  170 (100%)   
* NNEL – Non-neoplastic epithelial lesion
** According to Cassali et al., (2011)
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Figure 1 – Kaplan-Meier survival probability following 
mastectomy for 150 dogs grouped accord-
ing to histological tumor type as a prognostic 
factor. Log-rank test (Mantel-Cox) P = 0.1141 
Chi-square 5.950 DF = 3. Ductal carcinoma in 
situ not included
Source: (BIONDI et al., 2014)
Figure 2 – Kaplan-Meier survival probability following 
mastectomy for 150 dogs grouped according to 
histological grading of malignant tumors as a 
prognostic factor. Log-rank test (Mantel-Cox) 
P < 0.0001 Chi-square 21.26 DF = 2. Ductal 
carcinoma in situ not included
Source: (BIONDI et al., 2014)
Th e mean age at diagnosis was 9.3 ± 2.32 years, with 
lower and upper limits of, respectively, 2.4 and 9.3 
years. 
Th e study population consisted of diff erent breeds 
with diff erent reproductive status, predominantly 
non-castrated females (146/170), with mean age 
at sterilization surgery of 7 ± 3.42 – range of 0.5 to 
14 years. Information about the regularity of estrus, 
pseudopregnancy and use of hormonal therapy 
for heat prevention did not show any constancy in 
medical records, and therefore it could not be assessed 
with certainty to be included in this study. 
Th e greater relative frequency of mammary tumors 
was found in English cocker spaniel, boxer, German 
shepherd, and poodle female dogs (Table 2), with 
statistically signifi cant association between breed and 
mammary tumor (G-Test 57.0507 DF 9 P < 0.0001), 
however, no signifi cant statistical diff erence was 
found when comparing purebred and mongrel dog at 
Chi-square analysis (Chi-square 5.341 DF 1 P>0.05) 
or between animals grouped by size (p = 0.5857; Chi-
square 1.937, DF 3, n = 152), age at sterilization (p = 
0.9298; Chi-square 0.008; DF 1, n = 24) or previous 
castration (p = 0.1559; Chi-square 2.104, DF 1, n = 
152) at survival analysis.
Regarding tumor presentation, 100/170 (58.82%) 
animals had more than one tumor at diagnosis, 
22/170 (12.94%) had ulcerated tumors and 16/170 
(9.41%) had tumors adhered to deep tissues. Mean 
tumor size was 4.76 ± 3.86 cm, with lower and upper 
limits respectively 1.0 and 25.0 cm. Survival analysis 
of maximum tumor size as predictive variable 
showed signifi cant statistical diff erence with favorable 
prognosis among animals with tumors smaller than 
5 cm in diameter, as showed in fi gure 3. However, 
survival analysis between females with single 
Table 2 – Mammary neoplasm distribution among diff erent 
breeds in Santos – São Paulo – Brasil – 2014
                                                Mammary tumor 
Breed non aff ected aff ected (%) TOTAL
English cocker spaniel 269 19 (6.6) 288
boxer 144 9 (5.9)  153
German shepherd 266 14 (5.0) 280
poodle 940 41 (4.2) 981
pinscher 279 9 (3.1) 288
Labrador retriever 123 4 (3.1) 127
teckel 287 7 (2.4) 294
mongrel dog 2329 47 (2.0) 2376
rottweiler  287 4 (1.4) 291
other breeds 1322 11 (0.8) 1333
Total 6246 165 6411
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Figura 3 – Kaplan-Meier survival probability following 
mastectomy for 152 dogs grouped according 
to maximum tumor diameter as a prognostic 
factor. Log-rank test (Mantel-Cox) P = 0.0004 
Chi-square 12.5 DF = 1
Source: (BIONDI et al., 2014)
tumor presentation (63/152 females) or multiple 
presentations (89/152 females) did not show any 
statistical diff erence.
Although the presence of metastasis at diagnosis is 
considered an important prognostic factor and the 
mean survival time of animals with metastasis in this 
study was as small as 5 months, this variable was not 
considered for survival analysis purposes due to the 
limited number of animals within these conditions 
(three animals showed cutaneous metastasis of 
the mammary cancer, confi rmed by cytology and 
histopathology – tubular carcinoma grade I and II and 
a complex carcinoma grade II respectively, and only 
two animals showed lung metastasis, diagnosed by 
thoracic radiographic examination – solid carcinoma 
grade III; mixed carcinoma grade II respectively). 
Once WHO TNM classifi cation takes into account 
these parameters, distant and regional metastasis 
were both assessed by clinical staging. Th e survival 
analysis of the clinical stage as a predictive variable 
has shown signifi cant statistical diff erence between 
stages, as established at fi gure 4.
Forty-eight animals (48/170; 28.23%) underwent 
total mastectomy, 122/170 (71.76%) underwent 
partial mastectomy and 93 females (93/170; 54.70%) 
underwent ovariohysterectomy simultaneously. Among 
intact animals, no signifi cant diff erence was found at 
Figure 4 – Kaplan-Meier survival probability following 
mastectomy for 152 dogs grouped according 
to clinical stage based on WHO TNM method 
as a prognostic factor. Log-rank test (Mantel-
Cox) P = 0.0078 Chi-square 9.700 DF = 2
Source: (BIONDI et al., 2014)
survival analysis between individuals that underwent 
simultaneously ovariohysterectomy from those ones, 
not submitted to this surgery. Also, no signifi cant 
statistical diff erence at survival rate was found between 
animals submitted to radical or partial surgery.
Th e clinical follow-up showed recurrence or new 
mammary tumor presentation in nineteen (19/170; 
12.5%) females aft er mastectomy. Survival analysis 
of this predictive variable revealed statistically 
diff erence, with a 19 times greater risk for the group 
of recurrence or new tumors, as showed in fi gure 5 
(Hazard ratio 19.91; 95% CI of ratio = 7.904 to 50.17). 
Figure 5 – Kaplan-Meier survival probability following 
mastectomy for 152 dogs grouped according 
to recurrence or new tumor presentation as a 
prognostic factor. Log-rank test (Mantel-Cox) 
p < 0.0001 Chi-square 40.26 DF = 1 HR 19.91 
95% CI of ratio 7.904 to 50.17
Source: (BIONDI et al., 2014)
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Chemotherapy was performed in seventeen females 
that were submitted to adjuvant antineoplastic 
treatment with doxorubicin plus cyclophosphamide 
(TODOROVA et. al., 2005). Th ere was statistically 
signifi cant diff erence between treated and untreated 
groups according to log-rank test, as shown in fi gure 6.
Figure 6 – Kaplan-Meier survival probability following 
mastectomy for 152 dogs grouped according 
to adjuvant or neoadjuvant chemotherapy as a 
prognostic factor. Log-rank test (Mantel-Cox) 
P = 0.0104 Chi-square 6.650 DF = 1 HR 4.907 
95% CI of ratio 1.453 to 16.58
Source: (BIONDI et al., 2014)
At the end of the study, 42/170 (24.70%) animals 
were still alive, 80/170 (47.0%) had died and 48/170 
(28.23%) were missing in the follow-up. Amongst the 
deaths, 33/80 (41.25%) were attributed to mammary 
cancer, 9/80 (11.25%) to others tumors developed aft er 
mastectomy (liposarcoma, hemangioma, epidermoid 
carcinoma, fi brosarcoma, hemangiosarcoma, and 
osteosarcoma) and the remaining (38/80; 47.5%) to 
other causes as natural aging, heart failure or renal 
failure.
Th ere was no hematological or biochemical 
alteration that could be statistically related to 
mammary tumor and/or to the clinical course of the 
disease.
Cox multivariate proportional hazard model 
performed for selected covariate showed a highly 
signifi cant statistical diff erence with P < 0.0001 on 
overall model fi t (Table 3). Animals with tumors 
larger than 5 cm in diameter showed 72.1% greater 
likelihood to death than animals with smaller tumors. 
Th e same was observed regarding tumor grade, with 
75.5% and 90.1% probability of death, respectively 
for grades II and III, as well as to neoadjuvant 
chemotherapy and recurrence, with a likelihood 
respectively of 73.2 and 91.8% of death compared to 
control animals (untreated/no recurrence).
Discussion
Cancer clinicopathological studies in veterinary 
medicine are very important tools to better 
understand the behavior of cancer disease in a 
particular population and set further strategies for 
cancer control.
With this work, in a retrospective study of 6 years 
and based on a minimum 18 months follow-up, 
we were able to identify the specifi c frequency of 
diff erent histological types of mammary tumors in 
female dogs in our region, the signifi cant prevalence 
of malignant mammary tumors in this population 
and the importance of clinical staging and histologic 
tumor grade as prognostic factors on this disease. 
Table 3 –  Cox proportional hazard model for selected covariates. Canine mammary neoplasm in Santos – São Paulo – 
Brasil – 2014
Covariate  b SE P Exp(b) 95% CI of Exp(b)
Maximum tumor size = > 5 cm 0.9497 0.4685 0.0426 2.5848 1.0368 to 6.4442
Grade = II  1.1272 0.4884 0.0210 3.0869 1.1911 to 8.0000
Grade = III 2.2119 0.6740 0.0010 9.1326 2.4537 to 33.9909
Adjuvant chemotherapy = Yes 1.0026 0.4768 0.0355 2.7253 1.0756 to 6.9049
Recurrence = Yes 2.4147 0.4539 <0.0001 11.1864 4.6167 to 27.1049
P < 0.0001 for overall model fi t. Forward method
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The prevalence of mammary tumors diagnosis in 
the population of this study (53.6%) is in agreement 
with previous reports, which describe canine 
mammary neoplasm as a highly prevalent disease in 
dogs, ranging from 26 to 73% (ANDRADE et al., 2010; 
MUNSON; MORESCO, 2007; OLIVEIRA FILHO et 
al., 2010; PÉREZ-ALENZA et al., 2000). However, 
the high frequency of malignant tumors among the 
diagnosis of mammary neoplasia in this population 
is opposed to the literature that describes the disease 
in developed countries as around 50% (SLEECKX et 
al., 2011; SORENMO, 2003) but is in agreement with 
Brazilian reports. In fact, Toríbio et al. (2012), who 
studied a population of 132 female dogs carriers of 
mammary tumors from Salvador – Bahia – Brazil, 
observed a 90.9% malignant tumor frequency, similar 
to the results previously described by Filgueira, 
Araújo and Silva (2005), who studied 35 female dogs 
with this disease in Ceará – Brazil, and showed a 
70.4% frequency of adenocarcinomas, and by Oliveira 
Filho et al. (2010) who have obtained similar results 
in a study in Rio Grande do Sul – Brazil. Although 
this observation could be attributed to the high 
average age at which the animals were sterilized, one 
must consider that there is a growing concerning with 
the association between cancer and environmental 
pollutants in humans and studies have shown some 
pesticides acting as xenoestrogens and its relation with 
the increased incidence of cancer (SNEDEKER, 2001). 
Once the Port of Santos has an historic relation with 
environmental contamination, it could in principle 
be another explanation for the higher incidence of 
malignant mammary neoplasm in this population. 
Indeed, Zago et al. (2005) studying the mortality 
from breast cancer in women in the metropolitan 
area of Santos, found a significant difference between 
the mortality in this population, with 25/100,000 
cases per year versus 9.7/100,000 in other Brazilian 
regions, attributing this difference to soil and water 
contamination by organochlorines and dioxins in 
that region. In the veterinary filed, also Andrade et 
al. (2010), who have studied by chromatography the 
concentration of pyrethroids in the adipose tissue 
adjacent to mammary tumor in female dogs, warned 
to the high levels of contamination (33.3%) by 
different types of pyrethrins in this kind of tissue.
Although our findings about survival related to 
histological tumor type is in disagreement with 
current reports (GOLDSCHMIDT et al., 2011; 
PÉREZ-ALENZA et al., 2000; SLEECKX et al., 2011) 
the distribution for each histological type (Table 
1 and Figure 1) and the grading of histological 
malignancy (Figure 2), associating Grade III as 
the worst prognosis, is in according to previous 
reports and as expected (GOLDSCHMIDT et al., 
2011; KARAYANNOPOULUS; KALDRYMIDOU; 
CONSTANTINIDIS, 2005; PÉREZ-ALENZA et al., 
2000; SORENMO et al., 2011). On the other hand, we 
found a higher frequency of simple tubular tumors, 
followed by complex carcinomas, unlike Peña et al. 
(2013), who found greater number of complex tumors 
and adenosquamous carcinoma in a study that 
evaluated 65 female dogs with mammary tumors and 
Santos et al. (2013), who found a greater number of 
solid and complex carcinomas in a cohort of 80 female 
dogs with spontaneous mammary gland tumors.
The average age at diagnosis (9.3 ± 2.32 years) 
corroborate published reports that associated 
mammary gland tumors to middle-aged and old 
bitches (DALECK et al., 1998; PEÑA et al., 2013; 
SLEECKX et al., 2011; SORENMO et al., 2011). 
Although we also found statistical significance at the 
analysis of survival based on age (data not included), 
we decided, unlike Peña et al. (2013) disregard this 
variable as a prognostic factor, since age, by itself, 
is an unfavorable survival factor regardless of the 
neoplastic mammary disease.
The findings regarding mammary gland cancer 
and breed association are in agreement with current 
reports as discussed by Sorenmo et al. (2011), who 
considered that mammary tumors may occur in 
any female dog of any breed and the reported breed 
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vary somewhat depending on where these studies 
originate, as pointed by this work, where some pure 
breeds showed an increased risk. However, animal 
distribution by size to assess survival rate did not 
show any statistical significance or trend, unlike Itoh 
et al. (2005) and Peña et al. (2013) who found an 
increased survival in small breed animals, probably 
due to differences between the studied populations.
As described, tumor size was significantly associated 
with prognosis, with the worst course of the disease 
associated with higher than 5 cm diameter tumors. 
These data are in better agreement with the reports 
of Chang et al. (2005) and Yamagami (1996) who also 
conducted a long term study and found favorable 
prognosis for females carrying tumors smaller than 
5 cm. Also Ferreira et al. (2009) who studying tumor 
size and prognostic markers in 120 female dogs with 
mammary neoplasia, found lower survival rates and 
lower expression of progesterone receptors in those 
animals with tumors classified as T3 in the TNM 
system, ie, those larger than 5 cm in diameter and a 
higher expression of the proliferation marker MIB1 
(68%) in this kind of tumor, with significant difference 
between T1 and T3 tumors. In opposition, Peña et al. 
(2013) and Santos et al. (2013) considerate for statistical 
purposes, the limit of 3 cm for tumor diameter.
 Multiple versus simple tumor presentation has 
shown no significant difference in survival analysis, 
in disagreement with Pérez-Alenza et al. (1997), 
who associated disease free survival with multiple 
malignant tumor presentation. According to medical 
records, when at multiple presentation, the criterion 
for choice was the largest tumor size, making us 
unable to evaluate the different histological types 
that animals with more than one tumor may have 
presented. Taking into account that animals with 
multiple presentations are more exposed to tumor 
progression, it is possible that this finding is not 
consistent with the reality and was biased by the 
above mentioned criterion (SORENMO et al., 2009, 
2011).
The survival analysis of the clinical stage has shown 
significant statistical difference between stages, 
consistent with current literature (CASSALI et al., 
2011; CHANG et al., 2005; KARAYANNOPOULUS; 
KALDRYMIDOU; CONSTANTINIDIS, 2005; PEÑA 
et al., 2013; SLEECKX et al., 2011; YAMAGAMI et 
al., 1996) pointing this variable as an important and 
inexpensive tool available to clinicians. However it 
is remarkable the small number (5/170; 2.94%) of 
animals that developed metastatic disease, ie, stage 
grouping IV, as a result of neoplastic mammary 
disease. Whereas the follow-up was mainly based on 
phone contact, it is possible that among the deaths 
attributed by owners to breast tumors, have also 
been due metastatic disease, underestimating this 
observation.
An important issue that concerns clinicians is 
the value of simultaneous ovariohysterectomy 
at mastectomy. Statistical analysis indicated no 
significant difference between animals underwent to 
simultaneously ovariohysterectomy from that ones 
not submitted to surgery on survival rates, findings in 
agreement with Cassali et al. (2011) and as previously 
reported by Morris et al. (1998), who studied 90 
bitches followed for two years after mastectomy 
and grouped in spayed before the diagnosis, spayed 
simultaneously with surgical tumor removal and left 
entire. However this observation is disagreement 
with Sorenmo, Shofer and Goldschmidt (2000), who 
studied the effect of spaying and the timing of spaying 
on survival in 137 dogs with mammary gland tumors, 
grouped according to spay status and spay time, and 
considered ovariohysterectomy an effective adjunct 
to tumor removal in dogs with mammary gland 
carcinoma and the timing of ovariohysterectomy an 
important factor influencing survival. However, the 
authors did not evaluate the effect of simultaneously 
ovariohysterectomy and mastectomy. Another 
conflicting finding was reported by Peña et al. 
(2013), who described a better prognosis on non-
spayed females. Nonetheless, the authors did not 
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explain its apparently conflicting findings. Actually, 
in a systematic review regarding mammary tumors 
and neutering, Beauvais, Cardwell and Brodbelt 
(2012), evaluating papers published about this issue, 
concluded that there is no element that can support 
the recommendation of castration in reducing the 
risk of mammary tumors or that age at castration may 
influence this effect.
We did not also find any advantage between 
females submitted to partial or total mastectomy. 
In fact, the best choice for surgical treatment of 
mammary cancer in dogs (radical or partial excision/
simultaneous castration) is still controversial. In 
a study that evaluated 99 female dogs undergoing 
partial or radical mastectomy, although there was no 
difference in survival between the groups, the authors 
warn that 58% of the animals submitted to partial 
removal have shown new mammary neoplasms in 
the ipsilateral chain, requiring caution in the decision 
of keeping the mammary glands intact in these 
animals (STRATMANN et al., 2008), corroborating 
ours findings where animals with recurrence or 
presentation of new tumors showed a worse prognosis 
and a four time greater risk.
 Regarding adjuvant chemotherapy we had an 
interesting finding once untreated animals have 
presented a greater survival when compared with 
those animals submitted to adjuvant chemotherapy. 
This contradictory finding could be attributed to the 
unfavorable clinical preoperative conditions of these 
animals once the choice for chemotherapy inclusion 
is directed for those animals that have greater scores 
at clinical staging and/or unfavorable histopathology 
diagnosis. In addition, Cassali et al. (2011) highlights 
the limited information regarding the benefits of 
adjuvant chemotherapy in the treatment of mammary 
cancer in bitches nowadays. Indeed, in a recent 
work conducted from 2003 to 2012, Tran, Moore 
and Frimberger (2014), evaluating retrospectively 
94 animals with mammary carcinoma treated with 
surgery (58 animals) and adjuvant chemotherapy 
(36 animals), did not find statistically significant 
difference between groups treated and not treated 
with chemotherapy.
The deaths related to non-neoplastic diseases as well 
as the number of deaths from other diseases are in 
accordance to reports in the literature (BENJAMIN; 
LEE; SAUNDERS, 1999; STRATMANN et al., 2008). 
In fact, cancer has been considered a chronic disease 
in humans, and studies in the last decade have pointed 
to important differences between incidence and 
mortality, especially in patients with breast cancer 
(ALBERT; BENJAMIN; SHUKLA, 1994).
One of the limitations of our work was the difficulty 
to compare studies of survival and prognosis, once 
endpoints and different evaluation times are used 
between them. On average, several reports described 
studies with 18 to 24 month follow-up, whereas this 
study was based on 72 months follow-up, possible expla- 
nation for different findings with the current literature.
The results obtained in this study allow us to 
conclude that clinical staging of canine mammary 
neoplasms is an important and inexpensive prognostic 
factor for canine breast cancer. Furthermore, Cox 
multivariate proportional hazard model, associating 
tumor diameter, tumor grade, adjuvant chemotherapy 
and recurrence demonstrate that these covariates have 
great predictive value regarding the likelihood of death.
Moreover, the high prevalence of mammary 
malignant tumors, particularly tubular carcinoma, 
qualifies the canine population of Santos Metropolitan 
Region as a promising model for translational cancer 
studies. 
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